Acrivon Therapeutics, Inc. ($ACRV)
Filing Information
| Accession Number | 0000905148-26-000225 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 16, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
8,832
Total Value
$14,999.39
P&L
-2.3% ($338.27)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jan 14, 2026 | Purchase | 8,832 | $1.70 | $14,999.39 | 20,983 | Direct | โ | View Details |